212 related articles for article (PubMed ID: 31852898)
1. MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors.
Chen X; Burkhardt DB; Hartman AA; Hu X; Eastman AE; Sun C; Wang X; Zhong M; Krishnaswamy S; Guo S
Nat Commun; 2019 Dec; 10(1):5767. PubMed ID: 31852898
[TBL] [Abstract][Full Text] [Related]
2. EVI1 is critical for the pathogenesis of a subset of MLL-AF9-rearranged AMLs.
Bindels EM; Havermans M; Lugthart S; Erpelinck C; Wocjtowicz E; Krivtsov AV; Rombouts E; Armstrong SA; Taskesen E; Haanstra JR; Beverloo HB; Döhner H; Hudson WA; Kersey JH; Delwel R; Kumar AR
Blood; 2012 Jun; 119(24):5838-49. PubMed ID: 22553314
[TBL] [Abstract][Full Text] [Related]
3. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
[TBL] [Abstract][Full Text] [Related]
4. Malignant transformation initiated by Mll-AF9: gene dosage and critical target cells.
Chen W; Kumar AR; Hudson WA; Li Q; Wu B; Staggs RA; Lund EA; Sam TN; Kersey JH
Cancer Cell; 2008 May; 13(5):432-40. PubMed ID: 18455126
[TBL] [Abstract][Full Text] [Related]
5. The AAA+ ATPase RUVBL2 is a critical mediator of MLL-AF9 oncogenesis.
Osaki H; Walf-Vorderwülbecke V; Mangolini M; Zhao L; Horton SJ; Morrone G; Schuringa JJ; de Boer J; Williams O
Leukemia; 2013 Jul; 27(7):1461-8. PubMed ID: 23403462
[TBL] [Abstract][Full Text] [Related]
6. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
7. MLL-AF9 leukemia stem cells: hardwired or taking cues from the microenvironment?
Muntean AG; Hess JL
Cancer Cell; 2008 Jun; 13(6):465-7. PubMed ID: 18538728
[TBL] [Abstract][Full Text] [Related]
8. The miR-17-92 microRNA polycistron regulates MLL leukemia stem cell potential by modulating p21 expression.
Wong P; Iwasaki M; Somervaille TC; Ficara F; Carico C; Arnold C; Chen CZ; Cleary ML
Cancer Res; 2010 May; 70(9):3833-42. PubMed ID: 20406979
[TBL] [Abstract][Full Text] [Related]
9. IGF signaling contributes to malignant transformation of hematopoietic progenitors by the MLL-AF9 oncoprotein.
Jenkins CE; Shevchuk OO; Giambra V; Lam SH; Carboni JM; Gottardis MM; Holzenberger M; Pollak M; Humphries RK; Weng AP
Exp Hematol; 2012 Sep; 40(9):715-723.e6. PubMed ID: 22613471
[TBL] [Abstract][Full Text] [Related]
10. SIRT2 regulates proliferation and chemotherapy response of MLL-ENL-driven acute myeloid leukemia.
Hao C; Shao X; Song J; Peng M; Lao Y; Mack R; Zhang L; Wei W; Liu N; Wang T; Wu Y; Feng L; Yin L; Wang S; Sun X; Chen S; Zhang J; Li B
Biochem Biophys Res Commun; 2022 Mar; 596():36-42. PubMed ID: 35108652
[TBL] [Abstract][Full Text] [Related]
11. MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment.
Stubbs MC; Kim YM; Krivtsov AV; Wright RD; Feng Z; Agarwal J; Kung AL; Armstrong SA
Leukemia; 2008 Jan; 22(1):66-77. PubMed ID: 17851551
[TBL] [Abstract][Full Text] [Related]
12. Absence of the Shb gene in mixed-lineage leukemia MLL-AF9 cells increases latency in mice despite higher proliferation rates in vitro.
Jamalpour M; Bergquist E; Welsh M
Exp Cell Res; 2020 Dec; 397(2):112368. PubMed ID: 33220260
[TBL] [Abstract][Full Text] [Related]
13. Inducible MLL-AF9 Expression Drives an AML Program during Human Pluripotent Stem Cell-Derived Hematopoietic Differentiation.
Heuts BMH; Arza-Apalategi S; Alkema SG; Tijchon E; Jussen L; Bergevoet SM; van der Reijden BA; Martens JHA
Cells; 2023 Apr; 12(8):. PubMed ID: 37190104
[TBL] [Abstract][Full Text] [Related]
14. Atg5-dependent autophagy contributes to the development of acute myeloid leukemia in an MLL-AF9-driven mouse model.
Liu Q; Chen L; Atkinson JM; Claxton DF; Wang HG
Cell Death Dis; 2016 Sep; 7(9):e2361. PubMed ID: 27607576
[TBL] [Abstract][Full Text] [Related]
15. The leukemia-associated Mll-Ell oncoprotein induces fibroblast growth factor 2 (Fgf2)-dependent cytokine hypersensitivity in myeloid progenitor cells.
Shah CA; Bei L; Wang H; Platanias LC; Eklund EA
J Biol Chem; 2013 Nov; 288(45):32490-32505. PubMed ID: 24089521
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cells are intrinsically protected against MLL-ENL-mediated transformation.
Ugale A; Norddahl GL; Wahlestedt M; Säwén P; Jaako P; Pronk CJ; Soneji S; Cammenga J; Bryder D
Cell Rep; 2014 Nov; 9(4):1246-55. PubMed ID: 25456127
[TBL] [Abstract][Full Text] [Related]
17. Bahcc1 is critical for the aberrant epigenetic program in a mouse model of MLL-ENL-mediated leukemia.
Nakamura A; Masuya M; Shinmei M; Tawara I; Nosaka T; Ono R
Blood Adv; 2024 May; 8(9):2193-2206. PubMed ID: 38452334
[TBL] [Abstract][Full Text] [Related]
18. MLL-AF9-mediated immortalization of human hematopoietic cells along different lineages changes during ontogeny.
Horton SJ; Jaques J; Woolthuis C; van Dijk J; Mesuraca M; Huls G; Morrone G; Vellenga E; Schuringa JJ
Leukemia; 2013 Apr; 27(5):1116-26. PubMed ID: 23178754
[TBL] [Abstract][Full Text] [Related]
19. ZNF521 sustains the differentiation block in MLL-rearranged acute myeloid leukemia.
Germano G; Morello G; Aveic S; Pinazza M; Minuzzo S; Frasson C; Persano L; Bonvini P; Viola G; Bresolin S; Tregnago C; Paganin M; Pigazzi M; Indraccolo S; Basso G
Oncotarget; 2017 Apr; 8(16):26129-26141. PubMed ID: 28412727
[TBL] [Abstract][Full Text] [Related]
20. MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome.
Stavropoulou V; Kaspar S; Brault L; Sanders MA; Juge S; Morettini S; Tzankov A; Iacovino M; Lau IJ; Milne TA; Royo H; Kyba M; Valk PJM; Peters AHFM; Schwaller J
Cancer Cell; 2016 Jul; 30(1):43-58. PubMed ID: 27344946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
